The mediating role of new morbidities on social inequality in mortality after curative cancer treatment - a SEQUEL study.
1/5 보강
[BACKGROUND] Socioeconomic factors are linked to cancer survival.
- 95% CI 1.86-4.79
APA
Kjaer TK, Grand MK, et al. (2025). The mediating role of new morbidities on social inequality in mortality after curative cancer treatment - a SEQUEL study.. British journal of cancer, 133(12), 1880-1887. https://doi.org/10.1038/s41416-025-03225-9
MLA
Kjaer TK, et al.. "The mediating role of new morbidities on social inequality in mortality after curative cancer treatment - a SEQUEL study.." British journal of cancer, vol. 133, no. 12, 2025, pp. 1880-1887.
PMID
41057534 ↗
Abstract 한글 요약
[BACKGROUND] Socioeconomic factors are linked to cancer survival. While cancer stage and treatment mediate this association, the role of new morbidities after cancer treatment is less understood. We investigated educational disparities in cancer mortality and whether it is explained by differences in death from new morbidities.
[METHODS] 85,849 cancer survivors with lung, breast, prostate, colorectal cancers were included. Follow-up for overall and cause-specific death began one year after diagnosis, lasting up to 16 years. Cox proportional hazard models estimated the association between education and death. Mediation analyses explored whether new morbidities mediated this association.
[RESULTS] Survivors with short education had higher mortality, particularly after breast and colon cancers, with a significant proportion of deaths due to new morbidities (breast cancer e.g. new primary cancers (HR 1.59, 95% CI:1.35,1.87), kidney and urinary problems (HR 4.16, 95% CI:1.24,13.97), and chronic respiratory issues (HR 2.99, 95% CI:1.86-4.79). Similar trends were observed in colon cancer survivors e.g. ischemic heart disease (HR 1.70, 95% CI:1.13,2.56) and heart failure (HR 3.53, 95% CI:1.35,9.19). Although some new morbidities were statistically significant mediators, they accounted for only a small proportion of the effects.
[CONCLUSIONS] Educational disparities persist in cancer survivorship, with new morbidities contributing to higher mortality rates among survivors with shorter education.
[METHODS] 85,849 cancer survivors with lung, breast, prostate, colorectal cancers were included. Follow-up for overall and cause-specific death began one year after diagnosis, lasting up to 16 years. Cox proportional hazard models estimated the association between education and death. Mediation analyses explored whether new morbidities mediated this association.
[RESULTS] Survivors with short education had higher mortality, particularly after breast and colon cancers, with a significant proportion of deaths due to new morbidities (breast cancer e.g. new primary cancers (HR 1.59, 95% CI:1.35,1.87), kidney and urinary problems (HR 4.16, 95% CI:1.24,13.97), and chronic respiratory issues (HR 2.99, 95% CI:1.86-4.79). Similar trends were observed in colon cancer survivors e.g. ischemic heart disease (HR 1.70, 95% CI:1.13,2.56) and heart failure (HR 3.53, 95% CI:1.35,9.19). Although some new morbidities were statistically significant mediators, they accounted for only a small proportion of the effects.
[CONCLUSIONS] Educational disparities persist in cancer survivorship, with new morbidities contributing to higher mortality rates among survivors with shorter education.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.